You are here
AdvaMed Statement on Commissioner Hamburg
WASHINGTON, D.C. – Janet Trunzo, senior executive vice president for technology and regulatory affairs at the Advanced Medical Technology Association (AdvaMed), issued the following statement today upon news that FDA Commissioner Margaret Hamburg has decided to step down:
“We commend Commissioner Hamburg for her years of dedicated service to FDA and to American public health. It was under her leadership that the historic Medical Device User Fee Agreement III (MDUFA III) was struck, bringing significant new resources, accountability and improvements to the device review process. Much progress has been made, and her legacy will continue in the on-going program which ensures timely patient access to the best in medical care.
“In addition, she was a key advocate to strengthen oversight for certain laboratory-developed tests which have become far more complex and critical to patient care and medical decision making. We wish her continued success.”
# # #
AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit www.advamed.org.